Improving China＇s antiretroviral treatment program： assessing current and future performance using the principals of ethics

The global commitment to providing antiretroviral therapy （ART） to people living with human immunodeficiency virus/acquired immunodeficiency syndrome （HIV/AIDS） in low-income countries has raised hope that the increasing momentum in the fight against the worldwide HIV/AIDS pandemic will be sufficien...

Full description

Saved in:
Bibliographic Details
Published in:Chinese medical journal 2009, Vol.122 (11), p.1346-1351
Main Author: YIN Wen-yuan ZHANG Fu-jiet Naomi Juniper WU Zun-you
Format: Article
Language:English
Subjects:
人类免疫缺陷病毒
低收入国家
抗逆转录病毒治疗方案
抗逆转录病毒疗法
抗逆转录病毒药物
艾滋病毒感染者
获得性免疫缺陷综合症
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The global commitment to providing antiretroviral therapy （ART） to people living with human immunodeficiency virus/acquired immunodeficiency syndrome （HIV/AIDS） in low-income countries has raised hope that the increasing momentum in the fight against the worldwide HIV/AIDS pandemic will be sufficient to control it. However, improved availability of subsidized antiretroviral （ARV） treatments in low-income .countries raises complex ethical issues. In many resource-constrained countries the number of individuals infected with HIV in need of treatment far exceeds the supply of ARV medication. Resource allocation decisions can be made on the basis of many epidemiological, ethical, or preferential treatment priority criteria. Healthcare systems and funding in low-income countries are limited, requiring a step-by-step approach to scaling- up programs to reach their stated aims.
ISSN:0366-6999
2542-5641